Evidence-Based Oncology | September

Evidence-Based Oncology

Michael E. Chernew, PhD; Lee N. Newcomer, MD, MHA; and Sandra M. Swain, MD; examine the treatment benefits, cost concerns, and insurance coverage strategies for pertuzumab.
Targeted Therapies to Further Improve Outcomes

More issues

Compendia
Diabetes Compendium
HCV Compendium
Oncology Compendium
Reimbursement Compendium
Know Your News
HF Compendium
$vacMongoViewPlus$